Pharvaris NV (PHVS)
20.92
-0.79
(-3.64%)
USD |
NASDAQ |
May 17, 16:00
20.92
0.00 (0.00%)
After-Hours: 20:00
Pharvaris Free Cash Flow: -100.10M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -100.10M |
| December 31, 2023 | -100.83M |
| September 30, 2023 | -99.22M |
| June 30, 2023 | -87.16M |
| March 31, 2023 | -77.96M |
| December 31, 2022 | -70.96M |
| September 30, 2022 | -62.20M |
| Date | Value |
|---|---|
| June 30, 2022 | -59.98M |
| March 31, 2022 | -60.71M |
| December 31, 2021 | -52.92M |
| September 30, 2021 | -47.76M |
| June 30, 2021 | -44.64M |
| March 31, 2021 | -34.32M |
| December 31, 2020 | -24.60M |
Free Cash Flow Range, Past 5 Years
-100.83M
Minimum
Dec 2023
-24.60M
Maximum
Dec 2020
-65.95M
Average
-61.46M
Median
Free Cash Flow Benchmarks
| uniQure NV | -135.36M |
| ProQR Therapeutics NV | -43.28M |
| Merus NV | -150.28M |
| argenx SE | -- |
| Pharming Group | -3.493M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -26.32M |
| Cash from Investing (Quarterly) | -0.0334M |
| Cash from Financing (Quarterly) | 0.8636M |
| Free Cash Flow Per Share (Quarterly) | -0.4897 |
| Free Cash Flow Yield | -10.95% |